According to CASI Pharmaceuticals's latest financial reports the company's current earnings are NZ$31.56 Million. In 2024 the company made an earning of -NZ$65.46 Million a decrease over its 2023 earnings that were of -NZ$45.35 Million. The earnings displayed on this page is the company's Pretax Income.